The Impact of Missed Doses on Pharmacokinetic Concentrations for Oral Semaglutide in Comparison to Other Glucagon-Like Peptide-1-Based Therapies.

Saved in:
Bibliographic Details
Title: The Impact of Missed Doses on Pharmacokinetic Concentrations for Oral Semaglutide in Comparison to Other Glucagon-Like Peptide-1-Based Therapies.
Authors: Overgaard RV; Novo Nordisk A/S, Søborg, Denmark., Agersø H; Novo Nordisk A/S, Søborg, Denmark., Hollensen C; Novo Nordisk A/S, Søborg, Denmark., Rathor N; Novo Nordisk A/S, Søborg, Denmark., Bomberg EM; Department of Pediatrics, Center for Pediatric Obesity Medicine and Division of Endocrinology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jun 23. Date of Electronic Publication: 2026 Jun 23.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1463-1326
DOI:10.1111/dom.71030